Sign in
4

Changes in Ownership

Mirum Pharmaceuticals, Inc. Filed Acc 0001614740-25-000005

CHIEF EXECUTIVE OFFICER acquired 19,133 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Peetz Christopher · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-11-18 Exercise or conversion : show line 1 in the form +19,133 $19.24 $368,119 158,034 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-18 Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) −19,133 150,867 D
Loading xslF345X05/form4-11202025_091110.xml…